Edema - 306 Studies Found
| Completed |
: A Call Center During HAE Attacks (SOS HAE) : Hereditary Angioedema : 2012-08-21 : Other: phone to the call center recommendations to phone to the call center for all the patients who hav |
| Completed |
: A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor : Hereditary Angioedema : 2014-09-16 :
|
| Completed |
: The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria and/or Angioedema :
: 2005-09-12 : Behavioral: Dietary Therapy |
| Completed |
: Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE Attacks : Hereditary Angioedema : 2010-08-24 :
|
| Completed |
: Berinert P Study of Subcutaneous Versus Intravenous Administration : Hereditary Angioedema : 2008-09-04 : Drug: C1-Esterase Inhibitor 1000 I.E. Other Name: Be |
| Completed |
: Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema : Hereditary Angioedema : 2010-01-28 : Drug: ecallantide 30 mg SC Other Name: Kalbitor |
| Completed |
: A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE : Hereditary Angioedema : 2009-06-03 : Biological: C1 inhibitor (human) [C1 INH] Other Names:
|
| Completed |
: Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE : Hereditary Angioedema : 2011-10-13 : Drug: Icatibant 30 mg subcutaneous dose of Icatibant |
| Completed |
: Safety and Efficacy of Oral BCX4161 as a Prophylactic Treatment for HAE : Hereditary Angioedema : 2013-11-05 :
|
| Completed |
: EASSI - Evaluation of the Safety of Self-Administration With Icatibant : Hereditary Angioedema : 2009-10-16 : Drug: Icatibant Single subcutaneous injection of icatibant, 30 mg |